BioCentury | Mar 10, 2020
Finance

LSP to deploy $600M fund to retain larger stakes in early-stage European biotechs

LSP has formally closed its sixth fund at $600 million, the largest ever for a European life sciences fund. The firm joins a growing number of European VCs that have announced record fund-raisings in recent...
BioCentury | Feb 22, 2018
Finance

Belgian Insights

...In discussion with : Karen Bernstein, Ph.D., Chairman, BioCentury Inc. Rudy Dekeyser, Ph.D., Managing Partner, LSP Health Economics Fund...
BioCentury | Dec 15, 2017
Finance

LSP’s big cost-saving fund

...follow the same strategy. On Dec. 11, LSP announced the first and final close of LSP Health Economics Fund...
...companies. The first investment is expected to be announced early next year. Stephen Hansen, Associate Editor healthcare cost-saving LSP LSP Health Economics Fund...
BioCentury | Dec 15, 2017
Financial News

LSP closes second health economic fund at €280M

...LSP announced on Dec. 12 the close of LSP Health Economics Fund 2 at €280 million ($330.2 million), the...
BioCentury | Dec 12, 2017
Financial News

LSP closes second health economic fund at €280M

...LSP announced the close of LSP Health Economics Fund 2 at €280 million ($330.2 million), the largest private equity...
BioCentury | May 25, 2015
Finance

Cash cravings

...$187.4) Nov-14 Baird Capital Baird Venture Partners IV U.K. $185.0 Mar-14 LSP (Life Sciences Partners) LSP Health Economics Fund...
BioCentury | Dec 2, 2014
Financial News

MDx play Curetis adds to B round

...in an extension of its series B round. New investors Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) and LSP Health Economics Fund...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Divergent appetites

...$250 (A) Nov-13 Gilde Healthcare Gilde Healthcare III Netherlands €145 ($200) Mar-14 LSP-Life Sciences Partners LSP Health Economics Fund...
BioCentury | Mar 31, 2014
Finance

LSP's steady hand

...while remaining in the life sciences space. In 2012, LSP launched its third complementary vehicle, LSP Health Economics Fund...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...
Items per page:
1 - 10 of 13
BioCentury | Mar 10, 2020
Finance

LSP to deploy $600M fund to retain larger stakes in early-stage European biotechs

LSP has formally closed its sixth fund at $600 million, the largest ever for a European life sciences fund. The firm joins a growing number of European VCs that have announced record fund-raisings in recent...
BioCentury | Feb 22, 2018
Finance

Belgian Insights

...In discussion with : Karen Bernstein, Ph.D., Chairman, BioCentury Inc. Rudy Dekeyser, Ph.D., Managing Partner, LSP Health Economics Fund...
BioCentury | Dec 15, 2017
Finance

LSP’s big cost-saving fund

...follow the same strategy. On Dec. 11, LSP announced the first and final close of LSP Health Economics Fund...
...companies. The first investment is expected to be announced early next year. Stephen Hansen, Associate Editor healthcare cost-saving LSP LSP Health Economics Fund...
BioCentury | Dec 15, 2017
Financial News

LSP closes second health economic fund at €280M

...LSP announced on Dec. 12 the close of LSP Health Economics Fund 2 at €280 million ($330.2 million), the...
BioCentury | Dec 12, 2017
Financial News

LSP closes second health economic fund at €280M

...LSP announced the close of LSP Health Economics Fund 2 at €280 million ($330.2 million), the largest private equity...
BioCentury | May 25, 2015
Finance

Cash cravings

...$187.4) Nov-14 Baird Capital Baird Venture Partners IV U.K. $185.0 Mar-14 LSP (Life Sciences Partners) LSP Health Economics Fund...
BioCentury | Dec 2, 2014
Financial News

MDx play Curetis adds to B round

...in an extension of its series B round. New investors Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) and LSP Health Economics Fund...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Divergent appetites

...$250 (A) Nov-13 Gilde Healthcare Gilde Healthcare III Netherlands €145 ($200) Mar-14 LSP-Life Sciences Partners LSP Health Economics Fund...
BioCentury | Mar 31, 2014
Finance

LSP's steady hand

...while remaining in the life sciences space. In 2012, LSP launched its third complementary vehicle, LSP Health Economics Fund...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...
Items per page:
1 - 10 of 13